Analysts: Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Global Select Market

13.70USD
22 Sep 2014
Price Change (% chg)

$-0.35 (-2.49%)
Prev Close
$14.05
Open
$13.92
Day's High
$14.00
Day's Low
$13.16
Volume
526,491
Avg. Vol
548,511
52-wk High
$38.82
52-wk Low
$10.77

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.33 December 23 Sep 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 8 8 7 7
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.11 1.11 1.12 1.12

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 7 0.37 0.60 0.00 0.05
Quarter Ending Dec-14 8 0.36 0.66 0.00 0.05
Year Ending Dec-14 9 1.68 2.24 1.01 0.34
Year Ending Dec-15 8 1.04 3.20 0.00 2.14
Earnings (per share)
Quarter Ending Sep-14 8 -0.33 -0.29 -0.35 -0.25
Quarter Ending Dec-14 8 -0.34 -0.29 -0.39 -0.25
Year Ending Dec-14 9 -1.31 -1.20 -1.40 -1.02
Year Ending Dec-15 8 -1.34 -0.86 -1.72 -1.06

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-14 0.34 0.59 0.25 75.46
Quarter Ending Mar-14 0.25 0.42 0.16 64.69
Quarter Ending Dec-13 0.27 0.62 0.35 133.87
Quarter Ending Sep-13 0.09 0.98 0.89 1,014.90
Quarter Ending Jun-13 1.67 0.10 1.57 94.18
Earnings (per share)
Quarter Ending Jun-14 -0.32 -0.32 0.00 -0.90
Quarter Ending Mar-14 -0.26 -0.33 0.07 -25.71
Quarter Ending Dec-13 -0.28 -0.27 0.01 -3.16
Quarter Ending Sep-13 -0.24 -0.29 0.05 -18.95
Quarter Ending Jun-13 -0.22 -0.24 0.02 -7.67

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 0.37 0.37 0.37 0.36 0.05
Quarter Ending Dec-14 0.36 0.36 0.36 0.37 0.05
Year Ending Dec-14 1.68 1.68 1.68 1.49 0.34
Year Ending Dec-15 1.04 1.04 1.04 1.23 2.14
Earnings (per share)
Quarter Ending Sep-14 -0.33 -0.33 -0.33 -0.33 -0.25
Quarter Ending Dec-14 -0.34 -0.34 -0.34 -0.34 -0.25
Year Ending Dec-14 -1.31 -1.31 -1.31 -1.32 -1.02
Year Ending Dec-15 -1.34 -1.34 -1.34 -1.45 -1.06

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0
Earnings
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks